Latest stem cell therapy Stories
DUBLIN, May 12, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/sqctb8/stem_cell_therapy)
NEW YORK, May 6, 2014 /PRNewswire/ -- Brian Mehling, M.D., an American orthopedic trauma surgeon and founder of Blue Horizon International, was awarded a temporary license to practice medicine
The global stem cell therapy market on the basis of the mode of treatment is segmented into allogeneic and autologous stem cell therapy.
New research looking at the success of clinical trials of stem cell therapy shows that trials appear to be more successful in studies where there are more discrepancies in the trial data.
DALLAS, April 23, 2014 /PRNewswire/ -- According to the new research report "Stem Cell Therapy Market by Treatment Mode (Autologous & Allogeneic), Therapeutic Applications
Safety, Efficacy, Patient Satisfaction Drive StemGenex' Efforts toward Best-in-Class Stem Cell Treatment LA JOLLA, Calif., April 1, 2014 /PRNewswire/ --
$8.9M Raised in Last Round Enables Heart Institute to Treat Patients with Ischemic Conditions with Their Own Adult Stem Cells Beginning Summer, 2014 in the Bahamas Freeport,
New position focuses on StemGenex' commitment to safety and efficacy while developing new technology. LA JOLLA, Calif., March 18, 2014 /PRNewswire/ --
Adult Stem Cell Therapy Trade Organization Expands Advisory Board After Successful Global Conference with Researchers, Scientists, Regulatory Experts, Physicians And Investors Freeport,
The panel of presenters will discuss opportunities for medical industry start-ups in the Bahamas after recent stem cell research and Therapy Act Freeport, The
- an ornament or knob in the shape of a flower